ArticleLasers in medical science2026
Collagen remodeling drives continence recovery: radiofrequency therapy ameliorates SUI via TGF-β1/Smad2 pathway activation - evidence from a rat model.
Article in Lasers in medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Stress urinary incontinence (SUI) is one of the most prevalent pelvic floor disorders in women, and it is pathologically linked to collagen metabolism imbalance. Current treatments face limitations, including suboptimal efficacy and invasiveness. radiofrequency therapy (RF) therapy has emerged as a promising non-invasive approach, yet its precise mechanisms, particularly concerning collagen remodeling, remain inadequately elucidated.This study aimed to investigate the effects of RF on vaginal collagen metabolism in SUI rats and elucidate its underlying molecular mechanisms. An SUI rat model was created via vaginal dilation and bilateral ovariectomy. Rats were divided into Sham, SUI, SUI-No-RF, and SUI-RF (n = 7/group). The SUI-RF group received RF treatment (500 kHz, 2 W, 40 °C–42 °C) every 5 days for 3 sessions. At week 3 post-modeling, urodynamic measurements, Masson’s trichrome staining, immunofluorescence, Transmission Electron Microscopy (TEM), Western blot, and quantitative real-time polymerase chain reaction ( qPCR) were performed. Compared to the Sham group, SUI rats exhibited significantly reduced bladder leak point pressure (BLPP) and abdominal leak point pressure (ALPP) (p < 0.001). RF treatment markedly increased BLPP and ALPP in the SUI-RF group versus SUI-No-RF (p < 0.001), restoring urinary continence. Vaginal tissue in the SUI-RF group exhibited collagen volume fraction, elevated type III Collagen expression, and restored fibril alignment (p < 0.05). Mechanistically, RF treatment activated the Transforming Growth Factor-β1 (TGF-β1)/Smad2 pathway (increased TGF-β1 expression and Smad2 phosphorylation), upregulated tissue inhibitor of metalloproteinase 1 (TIMP1), and suppressed matrix metalloproteinase 9 (MMP9) expression (p < 0.05). RF therapy restores vaginal collagen architecture and continence function in SUI rats by activating the TGF-β1/Smad2 pathway and bidirectionally modulating the MMP9/TIMP1 equilibrium. These findings elucidate a molecular mechanism for RF therapy and support its further development as a non-invasive treatment for SUI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.